NDC 68462-331 – Pramipexole dihydrochloride
Pramipexole Dihydrochloride .25 mg/1 · Tablet · Oral
Product NDC68462-331
Product details
- Brand name
- Pramipexole dihydrochloride
- Generic name
- Pramipexole dihydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA090781
- Marketed since
- October 8, 2010
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonergot Dopamine Agonist
Active ingredients
- Pramipexole Dihydrochloride .25 mg/1
Uses, dosage, side effects and warnings for Pramipexole dihydrochloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 68462-331-05 | 500 TABLET in 1 BOTTLE (68462-331-05) | Oct 8, 2010 |
| 68462-331-11 | 10 BLISTER PACK in 1 CARTON (68462-331-11) / 10 TABLET in 1 BLISTER PACK | Oct 8, 2010 |
| 68462-331-90 | 90 TABLET in 1 BOTTLE (68462-331-90) | Oct 8, 2010 |
Other Pramipexole dihydrochloride products
- 50090-7816 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-2455 Pramipexole Dihydrochloride .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-3280 Pramipexole Dihydrochloride .25 mg/1 · Tablet · A-S Medication Solutions
- 50090-5036 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 62332-003 Pramipexole Dihydrochloride .125 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-156 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-005 Pramipexole Dihydrochloride .5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-007 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-006 Pramipexole Dihydrochloride 1 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-155 Pramipexole Dihydrochloride .75 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-004 Pramipexole Dihydrochloride .25 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-154 Pramipexole Dihydrochloride .375 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.